Modern Healthspan|07. Juni
The Multi-Modal Defense Against Cancer | Dr Tarek Mouhieddine
Summary: The Multi-Modal Defense Against Cancer - A Conversation with Dr. Tarek Mouhieddine
This video presents an innovative multi-modal approach to cancer early detection, designed to overcome the limitations of individual screening methods. Dr. Tarek Mouhieddine explains the concept of his company, Palm Health, which offers comprehensive and personalized cancer screening.
Key Points:
- The Problem: Many cancers are asymptomatic in their early stages. Traditional screenings like colonoscopies are logistically challenging and often avoided. A simple blood test could revolutionize prevention.
- The Palm Health Model: An online platform that connects healthy individuals without a cancer diagnosis to an oncologist. This is a significant advantage, as patients typically only see an oncologist after a diagnosis.
- The Multi-Cancer Blood Test ("Galleri"): The core test from Grail searches for DNA methylation signatures. Cancer cells shed DNA into the blood, and different cancers have unique methylation patterns ("fingerprints"). The test covers 50 cancer types.
- The Multi-Modal Strategy: To maximize detection rates, Palm Health combines multiple tests:
- Blood-based tests: The Galleri test, traditional tumor markers (e.g., CA-125, PSA), a complete blood count (CBC), flow cytometry (for blood cancers).
- Urine tests: For detecting bladder cancer or Multiple Myeloma.
- Imaging: A full-body MRI (Magnetic Resonance Imaging) without radiation, unlike CT scans.
- Process: The patient visits a Quest lab for a blood draw. Results are analyzed by the oncologist. If findings are positive, the patient is connected to a local oncologist for further diagnosis and treatment. The system is a telemedicine service that handles the first detection step and the referral to a specialist.
- Results: Dr. Mouhieddine reports cases where cancer was detected early through this system and patients were successfully guided to the right specialists.
- Limitations: No test is perfect. False negatives are possible. Some tumors may not shed cells or DNA into the blood. Therefore, combining multiple modalities (multi-modality) is crucial to increase accuracy. Example: Colorectal cancer is simultaneously screened for via Galleri, a tumor marker, and MRI.
